Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Binge Eating Disorder Pipeline Review H2 2016: Stage of Development and Molecule Type Analysis

Monday, November 14, 2016 3:28
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Latest Binge Eating Disorder Pipeline Review, H2 2016, provides in depth analysis on Cellular Tumor Antigen P53 (Tumor Suppressor P53 or Antigen NY-CO-13) targeted pipeline therapeutics.
 

Binge Eating Disorder therapeutics industry report provides comprehensive information on the therapeutics under development for Binge Eating Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Binge Eating Disorder and features dormant and discontinued projects.

Browse more detail information about Binge Eating Disorder market report at: http://www.absolutereports.com/binge-eating-disorder-pipeline-review-h2-2016-10405229

 

Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase your risk. Signs and symptoms include eating unusually large amounts of food, frequently eating alone, feeling that eating behavior is out of control and experiencing depression and anxiety. Treatment includes psychotherapy, medications and behavioral weight-loss programs.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Key players in Binge Eating Disorder – Pipeline Review, H2 2016:
 

  • Chronos Therapeutics Limited
  • F. Hoffmann-La Roche Ltd.
  • Heptares Therapeutics Limited
  • Highland Therapeutics, Inc.
  • Omeros Corporation
  • Opiant Pharmaceuticals, Inc.
  • Shire Plc
  • Sunovion Pharmaceuticals Inc.
     

Get a PDF Sample of Binge Eating Disorder Market Research Report at: http://www.absolutereports.com/enquiry/request-sample/10405229

Drug Profiles of Included in Binge Eating Disorder Therapeutics Development Market Report

  • RO-5256390
  • naloxone hydrochloride
  • OMS-527

And other drug profiles

Have any query? ask our expert @ http://www.absolutereports.com/enquiry/pre-order-enquiry/10405229

Key Topics Covered:
1.Introduction
2.Binge Eating Disorder Overview
3.Binge Eating Disorder Therapeutics Development
4.Pipeline Products for Binge Eating Disorder – Overview
5.Pipeline Products for Binge Eating Disorder – Comparative Analysis
6.Binge Eating Disorder – Therapeutics under Development by Companies
7.Binge Eating Disorder – Therapeutics under Investigation by Universities/Institutes
8.Binge Eating Disorder Products Glance
9.Late Stage Products
10.Clinical Stage Products
11.Early Stage Products
12.Binge Eating Disorder – Products under Development by Companies
13.Binge Eating Disorder – Products under Investigation by Universities/Institutes
14.Binge Eating Disorder – Companies Involved in Therapeutics Development
15.Binge Eating Disorder Drug Profiles
16.Binge Eating Disorder Dormant Projects
17.Binge Eating Disorder Discontinued Products
18.Binge Eating Disorder Featured News & Press Releases
And Continue…
 

Get Discount on Binge Eating Disorder Market Research Report at: http://www.absolutereports.com/enquiry/request-discount/10405229

This research study help to:
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Binge Eating Disorder
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Binge Eating Disorder pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

 

About Absolute Report:

Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.

Contact–

Mr. Ameya Pingaley

Absolute Reports

+1-408 520 9750

Email – sales@absolutereports.com

www.absolutereports.com

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.